Alberto Picca

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Venues

Brain communications

Cancers

Neuro-oncology advances

Neuro-oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Alberto Picca, Anna Luisa Di Stefano, Julien Savatovsky, François Ducray, Olivier Chinot, Elisabeth Cohen-Jonathan Moyal, Paule Augereau, Emilie Le Rhun, Yohann Schmitt, Nabila Rousseaux, Ariane Murielle Mbekwe Yepnang, Candice Estellat, Frédérique Charbonneau, Quentin Letourneur, Dominique Figarella Branger, David Meyronet, Christine Fardeau, Karima Mokhtari, Franck Bielle, Antonio Iavarone, Marc Sanson
TARGET: A phase I/II open-label multicenter study to assess safety and efficacy of fexagratinib in patients with relapsed/refractory FGFR fusion-positive glioma. Neuro-oncology advances 6 (1) (2024)
Alberto Picca, Anna Luisa Di Stefano, Julien Savatovsky, François Ducray, Olivier Chinot, Elisabeth Cohen-Jonathan Moyal, Paule Augereau, Emilie Le Rhun, Yohann Schmitt, Nabila Rousseaux, Ariane Murielle Mbekwe Yepnang, Candice Estellat, Frédérique Charbonneau, Quentin Letourneur, Dominique Figarella Branger, David Meyronet, Christine Fardeau, Karima Mokhtari, Franck Bielle, Antonio Iavarone, Marc Sanson
TARGET: A phase I/II open-label multicenter study to assess safety and efficacy of fexagratinib in patients with relapsed/refractory FGFR fusion-positive glioma. Neuro-oncology advances 6 (1) (2024)
Antonio Farina, Cristina Birzu, Mad-Hélénie Elsensohn, Alberto Picca, Sergio Muñiz-Castrillo, Alberto Vogrig, Macarena Villagrán-García, Nicolás Lundahl Ciano-Petersen, Luca Massacesi, Baptiste Hervier, Sarah Guégan, Nora Kramkimel, Yann Vano, Joe Elie Salem, Yves Allenbach, Thierry Maisonobe, Souad Assaad, Aurélien Maureille, Perrine Devic, Nicolas Weiss, Antoine Pegat, Delphine Maucort-Boulch, Damien Ricard, Jerome Honnorat, Dimitri Psimaras, Bastien Joubert
Neurological outcomes in immune checkpoint inhibitor-related neurotoxicity. Brain communications 5 (3) (2023)
Alberto Picca, Giulio Sansone, Orazio Santo Santonocito, Chiara Maria Mazzanti, Marc Sanson, Anna Luisa Di Stefano
Diffuse Gliomas with FGFR3-TACC3 Fusions: Oncogenic Mechanisms, Hallmarks, and Therapeutic Perspectives. Cancers 15 (23) (2023)
Antonio Farina, Cristina Birzu, Mad-Hélénie Elsensohn, Alberto Picca, Sergio Muñiz-Castrillo, Alberto Vogrig, Macarena Villagrán-García, Nicolás Lundahl Ciano-Petersen, Luca Massacesi, Baptiste Hervier, Sarah Guégan, Nora Kramkimel, Yann Vano, Joe Elie Salem, Yves Allenbach, Thierry Maisonobe, Souad Assaad, Aurélien Maureille, Perrine Devic, Nicolas Weiss, Antoine Pegat, Delphine Maucort-Boulch, Damien Ricard, Jerome Honnorat, Dimitri Psimaras, Bastien Joubert
Neurological outcomes in immune checkpoint inhibitor-related neurotoxicity. Brain communications 5 (3) (2023)
Antonio Farina, Cristina Birzu, Mad-Hélénie Elsensohn, Alberto Picca, Sergio Muñiz-Castrillo, Alberto Vogrig, Macarena Villagrán-García, Nicolás Lundahl Ciano-Petersen, Luca Massacesi, Baptiste Hervier, Sarah Guégan, Nora Kramkimel, Yann Vano, Joe Elie Salem, Yves Allenbach, Thierry Maisonobe, Souad Assaad, Aurélien Maureille, Perrine Devic, Nicolas Weiss, Antoine Pegat, Delphine Maucort-Boulch, Damien Ricard, Jerome Honnorat, Dimitri Psimaras, Bastien Joubert
Neurological outcomes in immune checkpoint inhibitor-related neurotoxicity. Brain communications 5 (3) (2023)
Alberto Picca, Francesco Bruno, Lucia Nichelli, Marc Sanson, Roberta Rudà
Advances in molecular and imaging biomarkers in lower-grade gliomas. Expert review of neurotherapeutics (2023)
Alberto Picca, David Guyon, Orazio Santo Santonocito, Capucine Baldini, Ahmed Idbaïh, Alexandre Carpentier, Antonio Giuseppe Naccarato, Mario Caccese, Giuseppe Lombardi, Anna Luisa Di Stefano
Innovating Strategies and Tailored Approaches in Neuro-Oncology. Cancers 14 (5) (2022)
Alberto Picca, Cristina Birzu, Giulia Berzero, Paola Sanchez-Pena, Louise Gaboriau, Faustine Vidil, Timothée Lenglet, Camille Tafani, Damien Ricard, Dimitri Psimaras, Kevin Bihan
Peripheral neuropathies after BRAF and/or MEK inhibitor treatment: A pharmacovigilance study. British journal of clinical pharmacology 88 (11) (2022)
Alberto Picca, Clément Desjardins, Kévin Bihan, Nicolas Weiss, Amélie Guihot, Lucia Nichelli, Loic Feuvret, Valerie Pourcher, Mehdi Touat, Caroline Dehais
Progressive multifocal leukoencephalopathy after first-line radiotherapy and temozolomide for glioblastoma. Neuro-oncology 24 (3) (2022)

Alberto Picca.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Alberto Picca